Am Heart J

1. KIM M, Ahn JM, Kang DY, Kim MJ, et al
   Low- or standard-dose edoxaban versus antiplatelet therapy for leaflet thrombus and cerebral thromboembolism after TAVR: A prespecified analysis of randomized ADAPT-TAVR trial.
   Am Heart J. 2024;269:167-178.
   

   >> Share

   
   

   
   Am J Cardiol

2. BRAUNWALD E
   Hypertrophic Cardiomyopathy: A Brief Overview.
   Am J Cardiol. 2024;212S:S1-S3.
   

   >> Share

   
   
3. ABRAHAM MR, Abraham TP
   Role of Imaging in the Diagnosis, Evaluation, and Management of Hypertrophic Cardiomyopathy.
   Am J Cardiol. 2024;212S:S14-S32.
   

   >> Share

   
   
4. HUTT E, Desai MY
   Medical Treatment Strategies for Hypertrophic Cardiomyopathy.
   Am J Cardiol. 2024;212S:S33-S41.
   

   >> Share

   
   
5. IRELAND CG, Ho CY
   Genetic Testing in Hypertrophic Cardiomyopathy.
   Am J Cardiol. 2024;212S:S4-S13.
   

   >> Share

   
   
6. BALI AD, Malik A, Naidu SS
   Treatment Strategies for Hypertrophic Cardiomyopathy: Alcohol Septal Ablation and Procedural Step-by-Step Technique.
   Am J Cardiol. 2024;212S:S42-S52.
   

   >> Share

   
   
7. SALBERG L
   Hypertrophic Cardiomyopathy: The Patient Perspective-Turning Tragedy into Action.
   Am J Cardiol. 2024;212S:S83-S86.
   

   >> Share

   
   
8. MARON BJ, Rowin EJ, Maron MS
   Advances in the Management of Hypertrophic Cardiomyopathy Leading to Low Disease-Related Mortality in 2023.
   Am J Cardiol. 2024;212S:S77-S82.
   

   >> Share

   
   
9. MARON MS, Rowin EJ, Maron BJ
   The Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy.
   Am J Cardiol. 2024;212S:S64-S76.
   

   >> Share

   
   
10. SCHAFF HV, Juarez-Casso FM
    Treatment Strategies for Hypertrophic Cardiomyopathy: Surgical.
    Am J Cardiol. 2024;212S:S53-S63.
    

    >> Share

    
    

    
    Ann Thorac Surg

11. SA MP, Jacquemyn X, Awad AK, Brown JA, et al
    Valve-Sparing Aortic Root Replacement With Reimplantation vs Remodeling: A Meta-analysis.
    Ann Thorac Surg. 2024;117:501-507.
    

    >> Share

    
    
12. KIM ER, Lee C, Lee CH, Cho SH, et al
    Long-term Outcomes of Polytetrafluoroethylene Bicuspid Pulmonary Valve Replacement.
    Ann Thorac Surg. 2024;117:535-541.
    

    >> Share

    
    
13. ROBERTS SH, Kaneko T
    Simplest Explanations to a Complex Problem: Does Hospital Volume Explain Variability in TAVR Cost?
    Ann Thorac Surg. 2024;117:533-534.
    

    >> Share

    
    
14. OKADA A, Beckmann E, Rocher EE, Fukui M, et al
    Preprocedural computed tomography planning for surgical aortic valve replacement.
    Ann Thorac Surg. 2024 Feb 19:S0003-4975(24)00121.
    

    >> Share

    
    
15. DEROO S, Aldea GS
    5-year COMMENCE Data Highlights Excellent Surgical Outcomes in Aortic Valve Replacement.
    Ann Thorac Surg. 2024 Feb 16:S0003-4975(24)00119.
    

    >> Share

    
    

    
    Cardiol Young

16. KASKI JP, Kammeraad JAE, Blom NA, Happonen JM, et al
    Indications and management of implantable cardioverter-defibrillator therapy in childhood hypertrophic cardiomyopathy: A position statement from the AEPC Working Group on Basic Science, Genetics and Myocardial Disease and the AEPC Working Group on Car
    Cardiol Young. 2024;34:469.
    

    >> Share

    
    
17. BRAUNLIN E, Bay L, Guffon N, Yang M, et al
    Natural history of cardiac findings in mucopolysaccharidosis type I: report from an international registry.
    Cardiol Young. 2024;34:401-411.
    

    >> Share

    
    
18. KARA KA, Arslanoglu E, Yigit F, Arkan C, et al
    The prognostic significance of early troponin levels in patients undergoing aortic ridge surgery.
    Cardiol Young. 2024;34:301-307.
    

    >> Share

    
    

    
    Circ Cardiovasc Interv

19. SHECHTER A, Lee M, Kaewkes D, Patel V, et al
    Implications of Mitral Annular Calcification on Outcomes Following Mitral Transcatheter Edge-to-Edge Repair.
    Circ Cardiovasc Interv. 2024;17:e013424.
    

    >> Share

    
    

    
    Circ Cardiovasc Qual Outcomes

20. ZHANG Y, Liu M, Zhang C, Zou Y, et al
    Role of Biomarkers of Myocardial Injury to Predict Adverse Outcomes in Hypertrophic Cardiomyopathy.
    Circ Cardiovasc Qual Outcomes. 2024;17:e010243.
    

    >> Share

    
    

    
    Circ Genom Precis Med

21. HERMIDA A, Ader F, Millat G, Jedraszak G, et al
    NEXN Gene in Cardiomyopathies and Sudden Cardiac Deaths: Prevalence, Phenotypic Expression, and Prognosis.
    Circ Genom Precis Med. 2024;17:e004285.
    

    >> Share

    
    
22. HAYESMOORE JBG, Bowman M, Shannon N, Blair E, et al
    A Promoter Deletion Confirms That MYBPC3 Haploinsufficiency Is Sufficient to Cause Hypertrophic Cardiomyopathy in Humans.
    Circ Genom Precis Med. 2024;17:e004134.
    

    >> Share

    
    
23. SHAUER A, Horowitz-Cederboim S, Mor-Shaked H, Durst R, et al
    Calmodulinopathy Associated Long QT Syndrome, Hypertrophic Cardiomyopathy With Excessive Trabeculation in a 14-Year-Old Girl Presenting With Ventricular Fibrillation.
    Circ Genom Precis Med. 2024 Jan 23:e004163. doi: 10.1161/CIRCGEN.123.004163.
    

    >> Share

    
    

    
    Circ Heart Fail

24. LEGEAI C, Coutance G, Cantrelle C, Jasseron C, et al
    Waitlist Outcomes in Candidates With Rare Causes of Heart Failure After Implementation of the 2018 French Heart Allocation Scheme.
    Circ Heart Fail. 2024 Feb 1:e010837. doi: 10.1161/CIRCHEARTFAILURE.123.010837.
    

    >> Share

    
    

    
    Eur Heart J

25. WU J, Zafar MA, Elefteriades JA
    Decision-making in aortic disease.
    Eur Heart J. 2024;45:633-634.
    

    >> Share

    
    
26. MESSIKA-ZEITOUN D, Iung B, Baumgartner H
    The year in cardiovascular medicine 2023: the top 10 papers in valvular heart disease.
    Eur Heart J. 2024 Feb 21:ehae090. doi: 10.1093.
    

    >> Share

    
    
27. LURZ P, Kresoja KP
    Surgical or percutaneous treatment of mitral regurgitation: clip or cut?
    Eur Heart J. 2024 Feb 21:ehae084. doi: 10.1093.
    

    >> Share

    
    

    
    Heart

28. UBBEN T, Frerker C, Fujita B, Rosenkranz S, et al
    Association of pulmonary hypertension with the outcome in patients undergoing edge-to-edge mitral valve repair.
    Heart. 2024 Feb 22:heartjnl-2023-323473. doi: 10.1136/heartjnl-2023-323473.
    

    >> Share

    
    

    
    Int J Cardiol

29. ALTIBI AM, Sapru A, Ghanem F, Zhao Y, et al
    Impact of concomitant surgical interventions on outcomes of septal myectomy in obstructive hypertrophic cardiomyopathy.
    Int J Cardiol. 2024;400:131790.
    

    >> Share

    
    
30. MUSUMECI B, Tini G, Biagini E, Merlo M, et al
    Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes.
    Int J Cardiol. 2024 Jan 18:131784. doi: 10.1016/j.ijcard.2024.131784.
    

    >> Share

    
    
31. DE SA MARCHI MF, van den Dorpel M, Calomeni P, Chatterjee S, et al
    Comparative analysis of different risk prediction tools after mitral Transcatheter edge-to-edge repair.
    Int J Cardiol. 2024;400:131768.
    

    >> Share

    
    
32. HIRAM R
    The duration of atrial fibrillation might be associated with right heart disease severity.
    Int J Cardiol. 2023 Dec 28:131689. doi: 10.1016/j.ijcard.2023.131689.
    

    >> Share

    
    
33. BOURG C, Lee KC, Donal E
    Understanding myocardial mechanics in primary mitral regurgitation: A contemporary approach.
    Int J Cardiol. 2024 Feb 17:131882. doi: 10.1016/j.ijcard.2024.131882.
    

    >> Share

    
    
34. DI MAURO M, Guarracini S, Mazzocchetti L, Capuzzi D, et al
    Transcatheter bicaval valve system for the treatment of severe isolated tricuspid regurgitation. Features from a single-Centre experience.
    Int J Cardiol. 2024 Feb 16:131864. doi: 10.1016/j.ijcard.2024.131864.
    

    >> Share

    
    
35. FATIMA K, Uddin QS, Tharwani ZH, Kashif MAB, et al
    Concomitant transthyretin cardiac amyloidosis in patients undergoing TAVR for aortic stenosis: A systemic review and meta-analysis.
    Int J Cardiol. 2024 Feb 15:131854. doi: 10.1016/j.ijcard.2024.131854.
    

    >> Share

    
    

    
    Pediatr Cardiol

36. LOU Y, Zhao B, Pan M, Huang L, et al
    Quantitative Analysis of Morphology and Function in the Fetal Heart with Severe Tricuspid Regurgitation by Speckle Tracking Imaging.
    Pediatr Cardiol. 2024 Feb 23. doi: 10.1007/s00246-024-03454.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share